Skip to search formSkip to main contentSkip to account menu

Angiotensin 2 Receptor Blocker [EPC]

Known as: Angiotensin 2 Receptor Blocker, Angiotensin II Receptor Blocker 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND The aim of this study was to evaluate the effect of olmesartan medoxomil (Olme), an angiotensin II receptor antagonist… 
2013
2013
BackgroundCilnidipine (Cil) is an L/N-type calcium channel blocker (CCB) that is known to provide renal protection by decreasing… 
2013
2013
There are several widely used combinations of angiotensin II receptor blocker (ARB)/thiazide. The complimentary mechanism of… 
2011
2011
The effects of 24 weeks' treatment with an angiotensin 2 receptor blocker (ARB)/diuretic combination drug were investigated in an… 
2011
2011
The clinical course of losartan potassium/hydrochlorothiazide (Preminent®)-induced hyponatremia has not been described. We… 
2010
2010
This study aimed to investigate the inhibitory effect of Bupleurum falcatum and its combination with angiotensin II receptor… 
2007
2007
Repolarization alternans, which can be detected clinically as microvolt-level T-wave alternans (TWA), is considered an important… 
2005
2005
The purpose of this study is to compare the long-term effects of an angiotensin II receptor blocker (ARB) and a long-acting… 
2003
2003
Abstract We reported that the initial beneficial effects of left ventricular repair (LVR) surgery for LV aneurysm after…